<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03967353</url>
  </required_header>
  <id_info>
    <org_study_id>D 181100000418002</org_study_id>
    <nct_id>NCT03967353</nct_id>
  </id_info>
  <brief_title>Study on the Management Model of &quot;Home Treatment&quot; for Tuberculosis Patients</brief_title>
  <official_title>Study on the Management Model of &quot;Home Treatment&quot; for Tuberculosis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Chest Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chest Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims to standardize the management of &quot;home treatment&quot; for tuberculosis
      patients, improve the compliance of patients with treatment, reduce the risk of transmission,
      and study the establishment of &quot;home treatment&quot; management model for tuberculosis patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The project intends to optimize the standardized management framework and process of &quot;home
      treatment&quot; for tuberculosis patients by introducing mobile Internet technology as a means of
      patient management and formulating &quot;home treatment&quot; infection control norms, and ultimately
      form a management model suitable for &quot;home treatment&quot; for tuberculosis patients.Through
      prospective study to evaluate the effect of this model on the treatment compliance of &quot;home
      treatment&quot; patients and the impact on tuberculosis infection and incidence of close contacts,
      so as to further improve the &quot;home treatment&quot; management model. The research results of this
      project will provide policy basis for Beijing to formulate &quot;home treatment&quot; management of
      tuberculosis progress.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2018</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>treatment adherence</measure>
    <time_frame>6 months for each patient</time_frame>
    <description>to compare the adherence rate of the two groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>treatment success rate</measure>
    <time_frame>6 months for each patient</time_frame>
    <description>to compare the success rate of the two groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Tuberculosis, Pulmonary</condition>
  <arm_group>
    <arm_group_label>Routine Treatment Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Routine treatment group(6 months treatment regimen-2HRZE/4HR); Routine health education; Dose-taken supervised by family members</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using mobile technology management means to manage newly treated smear-positive tuberculosis patients, to guide patients'treatment, infection control, doctor-patient communication, and to strengthen health education on infection control of patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>New management mode intervention</intervention_name>
    <description>Patients in routine treatment group use &quot;TB assistant APP&quot;. Medical staff strengthen health promotion of the patients,including, infection control, doctor-patient communication, etc.</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Pathogenic Comfirmed Positive TB patients New Pathogenic Positive Pulmonary Tuberculosis
        Patients Treated by Home Treatment TB assistant APP user

        Exclusion Criteria:

        Unconscious Unable to answer questions

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>fengling Mi, Master</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Chest Hospital, Capital Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>xiaoying Jiang, Ph.D</last_name>
    <phone>861089509298</phone>
    <email>kyb6295@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Chest Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>101149</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>di zhang, master</last_name>
      <phone>861089509298</phone>
      <email>kyb6295@sina.com</email>
    </contact>
    <investigator>
      <last_name>fengling Mi, master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 23, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2019</study_first_posted>
  <last_update_submitted>May 28, 2019</last_update_submitted>
  <last_update_submitted_qc>May 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chest Hospital</investigator_affiliation>
    <investigator_full_name>FengLing Mi</investigator_full_name>
    <investigator_title>vice director of office of academic research</investigator_title>
  </responsible_party>
  <keyword>Tuberculosis</keyword>
  <keyword>Home Treatment Management</keyword>
  <keyword>Infection Control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Tuberculosis, Pulmonary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>To share the data to main researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

